Production and purification of recombinant fragment of pneumococcal surface protein A (PspA) in Escherichia coli

Procedia in Vaccinology

Volumn 4, Issue , 2011, Pages 27-35

  Barazzone, Giovana C ^a   Carvalho, Rimenys ^a   Kraschowetz, Stefanie ^b   Horta, Antonio L ^b   Sargo, Cíntia R ^b   Silva, Adilson J ^b   Zangirolami, Teresa C ^b   Goulart, Cibelly ^a   Leite, Luciana C C ^a   Tanizaki, Martha M ^a   Gonçalves, Viviane M ^a   Cabrera Crespo, Joaquin ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Production; PspA; Purification; Streptococcus pneumoniae

Indexed keywords

BACTERIAL PROTEIN; GLYCEROL; PNEUMOCOCCAL SURFACE PROTEIN A; SEPHAROSE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANION EXCHANGE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOREACTOR; CARBON SOURCE; CENTRIFUGATION; CROSS REACTION; DENSITOMETRY; ESCHERICHIA COLI; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; STREPTOCOCCUS PNEUMONIAE;

EID: 80053408018     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.07.005     Document Type: Article

References (21)

1. Gray B.M., Turner M.E., Dilon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: the effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Amer J Epidem 1982, 116:692-703.
2. Rosen C., Christensen P., Hovelius B. A longitudinal study of nasopharyngeal carriage of pneumococci related to pneumococcal vaccination in children attending day-care centers. Acta Otolaryng 1984, 98:524-532.
3. Lee C.J., Banks S.D., Lee J.P. Virulence. Immunity, and vaccine related to Streptococcus pneumoniae. Crit Rev Microbiol 1991, 18:89-114.
4. Brandileone M.C., de Andrade A.L., Di Fabio J.L., Guerra M.L., Austrian R. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis. J Infect Dis 2003, 187:1206-1212.
5. Spika J.S., Facklam R.R., Pikaytis B.D., Oxtoby M.J., Party P.S.W. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991, 163:1273-1278.
6. Wenger JD, Booy R, Heath PT, Moxon R. Epidemiological impact of conjugate vaccines on invasive disease caused by Haemophilus influenzae type b. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New generation vaccines. 2nd ed. New York: Marcel Dekker; 1997, p. 489-502.
7. Schneerson R., Robbins J.B., Parke J.C. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus conjugates. Infect Immun 1986, 502:519-528.
8. Eby R, Koster M, Hogerman D. Pneumococcal conjugates. In: Norrby E, Brown F, Chanock RM, Ginsberg HS, editors. Vaccinesó94: Modern approaches to new vaccines including prevention of AIDS. New York: Cold Spring Harbor Laboratory Press; 1994, p. 119-24.
9. Vella P., Marburg S., Staub J., Kniskern P.J., Milelr W., Hagopian A., et al. Immunogenicity of conjugate vaccines consisting of pneumococcal polysaccharide type 6B, 14, 19F and 23F and a meningococcal outer membrane protein complex. Infect Immun 1992, 60:4977-4983.
10. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995, 33:2759-2762.
11. Siber G.R. Pneumococcal disease: prospects for a new generation vaccine. Science 1994, 265:1385-1387.
12. Daniels C.C., Briles T.C., Mirza S., Anders P., Hakansson A.P., Briles D.E. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae. Microb Pathog 2006, 40:228-233.
13. McDaniel L.S., Ralph B.A., McDaniel D.O., Briles D.E. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb Pathog 1994, 17:323-337.
14. Tai S.S. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol 2006, 32:139-153.
15. Hollingshead S.K., Becker R.S., Briles D.E. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 2000, 68:5889-5900.
16. Shiloach J., Fass R., Growing E. coli to high cell density - a historical perspective on method development. Biotechnol Adv 2005, 23:345-357.
17. Asenjo J.A., Andrews B.A. Protein purification using chromatography: selection of type, modeling and optimization of operating conditions. J Mol Recognit 2009, 22:65-76.
18. Xindu G., Lili W. Liquid chromatography of recombinant proteins and protein drugs - review. J Chomatog B 2008, 866:133-153.
19. Seeger A., Schneppe B., Mccarthy J.E.G., Deckwer W.D., Rinas U. Comparison of temperature-induced and isopropyl-beta-dthiogalacto-pyranoside-induced synthesis of basic fibroblast growth-factor in high-cell-density cultures of recombinant Escherichia coli. Enz Microb Technol 1995, 17:947-953.
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
21. Laemmli U.K., Beguin F., Gujer-Kellenberger G. A factor preventing the major head protein of bacteriophage T4 from random aggregation. J Mol Biol 1970, 47:69-85.